$237.100
+0.545 (+0.23%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ALNY por análisis de gráficos similares
Alphio's ALNY stock price prediction model matches the current Alnylam Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $233.66 (-1.45%). The 1-week path is $248.79 (+4.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals Inc is currently a hold. The stock is trading at $237.10, which is above the Fibonacci Pivot level of $233.68, indicating some short-term support. However, the stock has seen a significant decline of 40.75% year-to-date and 46.96% over the past year, raising concerns about its stability. The RSI is at 54.77, suggesting it is neither overbought nor oversold, which aligns with a cautious approach. The forward P/E ratio is 27.55, indicating that the stock is relatively expensive compared to its expected earnings growth. Analyst ratings vary, with a price target range from $230 to $455, showing mixed sentiment. The main risk is the recent negative trial results impacting its ATTR drug business, which could further pressure the stock.
ALNY cerró en $237.10 el Friday, tras subir +0.23%
Alnylam Pharmaceuticals, Inc. (ALNY) last closed at $237.1, gaining +0.23%. These facts feed the 1-day and 1-week ALNY price prediction above.
Consenso de analistas
Alnylam Pharmaceuticals, Inc. (ALNY): 13 comprar, 4 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Alnylam Pharmaceuticals, Inc. (ALNY) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ALNY, ordenadas por similitud.
Análisis de estacionalidad de ALNY
Historically the probability of a positive August return for ALNY is 68.25%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ALNY
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $338.07 | $364.02 | $415.70 | +53.53% |
| Sep 2026 | $202.52 | $289.06 | $437.23 | +21.91% |
| Oct 2026 | $350.62 | $412.92 | $470.51 | +74.16% |
| Nov 2026 | $361.56 | $412.92 | $530.74 | +74.16% |
| Dec 2026 | $182.69 | $289.06 | $422.33 | +21.91% |
En 2026, se proyecta que Alnylam Pharmaceuticals, Inc. (ALNY) oscile entre $182.69 y $530.74.
Previsión mensual de Alnylam Pharmaceuticals, Inc. para 2026
En Aug de 2026, se proyecta que Alnylam Pharmaceuticals, Inc. promedie $364.02, con un mínimo de $338.07 y un máximo de $415.70.
En Sep de 2026, se proyecta que Alnylam Pharmaceuticals, Inc. promedie $289.06, con un mínimo de $202.52 y un máximo de $437.23.
En Oct de 2026, se proyecta que Alnylam Pharmaceuticals, Inc. promedie $412.92, con un mínimo de $350.62 y un máximo de $470.51.
En Nov de 2026, se proyecta que Alnylam Pharmaceuticals, Inc. promedie $412.92, con un mínimo de $361.56 y un máximo de $530.74.
En Dec de 2026, se proyecta que Alnylam Pharmaceuticals, Inc. promedie $289.06, con un mínimo de $182.69 y un máximo de $422.33.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.